Search research articles
Contact Us
Filters
Showing results (11-20 of 75) with videos related to
Page
of 8
Sort By:
The Laryngoscope
|
October 8, 2010
Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma
Shivan H Amin, Raoul Tibes, Ji-Eon Kim, et al.
Molecular Diagnosis & Therapy
|
October 2, 2012
Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms
Raoul Tibes, James M Bogenberger, Kasey L Benson, et al.
Blood
|
October 14, 2006
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
Elihu Estey, Marcos de Lima, Raoul Tibes, et al.
Molecular Cancer Therapeutics
|
October 17, 2006
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
Raoul Tibes, Yihua Qiu, Yiling Lu, et al.
British Journal of Haematology
|
December 7, 2007
PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation
Raoul Tibes, Steven M Kornblau, Yihua Qiu, et al.
Computational and Structural Biotechnology Journal
|
October 27, 2018
Triazolo[4,5<i>-d</i>]pyrimidines as Validated General Control Nonderepressible 2 (GCN2) Protein Kinase Inhibitors Reduce Growth of Leukemia Cells
Lea Lough, Dan Sherman, Manuel Beccera-Flores, et al.
Gynecologic Oncology
|
August 20, 2010
RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells
Shilpi Arora, Kristen M Bisanz, Lourdes A Peralta, et al.
Cancer Chemotherapy and Pharmacology
|
November 27, 2012
A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors
Raoul Tibes, Gil Fine, Gavin Choy, et al.
Dermatology Reports
|
November 12, 2014
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
Glen J Weiss, Raoul Tibes, Lisa Blaydorn, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
October 13, 2016
Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit
Leslie Padrnos, Robert Bennett, Heidi Kosiorek, et al.
Page
of 8
Search research articles
Search
Showing results (11-20 of 75) with videos related to
Sort By:
Page
of 8
The Laryngoscope
|
October 8, 2010
Hedgehog antagonist GDC-0449 is effective in the treatment of advanced basal cell carcinoma
Shivan H Amin, Raoul Tibes, Ji-Eon Kim, et al.
Molecular Diagnosis & Therapy
|
October 2, 2012
Current outlook on molecular pathogenesis and treatment of myeloproliferative neoplasms
Raoul Tibes, James M Bogenberger, Kasey L Benson, et al.
Blood
|
October 14, 2006
Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)
Elihu Estey, Marcos de Lima, Raoul Tibes, et al.
Molecular Cancer Therapeutics
|
October 17, 2006
Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells
Raoul Tibes, Yihua Qiu, Yiling Lu, et al.
British Journal of Haematology
|
December 7, 2007
PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutation
Raoul Tibes, Steven M Kornblau, Yihua Qiu, et al.
Computational and Structural Biotechnology Journal
|
October 27, 2018
Triazolo[4,5<i>-d</i>]pyrimidines as Validated General Control Nonderepressible 2 (GCN2) Protein Kinase Inhibitors Reduce Growth of Leukemia Cells
Lea Lough, Dan Sherman, Manuel Beccera-Flores, et al.
Gynecologic Oncology
|
August 20, 2010
RNAi screening of the kinome identifies modulators of cisplatin response in ovarian cancer cells
Shilpi Arora, Kristen M Bisanz, Lourdes A Peralta, et al.
Cancer Chemotherapy and Pharmacology
|
November 27, 2012
A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors
Raoul Tibes, Gil Fine, Gavin Choy, et al.
Dermatology Reports
|
November 12, 2014
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome
Glen J Weiss, Raoul Tibes, Lisa Blaydorn, et al.
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education
|
October 13, 2016
Living with Cancer: an Educational Intervention in Cancer Patients Can Improve Patient-Reported Knowledge Deficit
Leslie Padrnos, Robert Bennett, Heidi Kosiorek, et al.
Page
of 8